Clinical Trial Update: A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effects of ustekinumab (Stelara) and etanercept (Enbrel) in adults with moderate to severe psoriasis; results were posted after com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• ENBREL (etanercept)
• Stelara (ustekinumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2013-02-28